Skip to main content
. 2016 Apr 8;7(29):45079–45093. doi: 10.18632/oncotarget.8650

Figure 5. In vitro-sensitivity of activated mouse and human lymphocytes to p53 SMWC.

Figure 5

Viability of Con A-activated mouse splenocytes, rmIFNγ activated mouse macrophages, bone marrow-derived mouse dendritic cells, and PHA-activated PBMC following activation in the presence of p53 SWMC. See Materials and Methods for additional details.